Skip to Content
Merck
  • Synthesis of novel 7-benzylamino-2H-1,4-benzoxazin-3(4H)-ones as anticonvulsant agents.

Synthesis of novel 7-benzylamino-2H-1,4-benzoxazin-3(4H)-ones as anticonvulsant agents.

European journal of medicinal chemistry (2007-10-24)
Zhong-Tai Piao, Li-Ping Guan, Li-Ming Zhao, Hu-Ri Piao, Zhe-Shan Quan
ABSTRACT

A series of 7-benzylamino-2H-1,4-benzoxazin-3(4H)-ones were synthesized using 2-amino-5-nitrophenol as a starting material. Their anticonvulsant activities were evaluated by the maximal electroshock test (MES test) and their neurotoxicity was evaluated by the rotarod neurotoxicity test (Tox.). The MES test showed that 7-(4-fluorobenzylamino)-2H-1,4-benzoxazin-3(4H)-one 4b was the most potent with ED(50) value of 31.7 mg/kg and protective index (PI=TD(50)/ED(50)) value of 7.2. To explain the possible mechanism of anticonvulsant activity, the compound 4b was tested in sc-PTZ test, isoniazid test and strychnine test.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Carbamazepine, meets USP testing specifications
Sigma-Aldrich
Carbamazepine, powder
Sigma-Aldrich
2-Amino-5-nitrophenol
Sigma-Aldrich
5,5-Diphenylhydantoin, ≥98%